|
1
|
Ovarian Cancer 2014 Report. World Cancer
Research Fund/American Institute for Cancer Research, Food,
Nutrition, Physical Activity, and the Prevention of Cancer.
https://www.wcrf.org/sites/default/files/Ovarian-Cancer-2014-Report.pdfAccessed.
July 21–2014
|
|
2
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality
Worldwide: IARC CancerBase No. 11 [Internet]. (Lyon, France).
International Agency for Research on Cancer. simpleglobocan.iarc.frAccessed. July 21–2014
|
|
3
|
Sung PL, Chang YH, Chao KC and Chuang CM:
Task Force on Systematic Review and Meta-analysis of Ovarian
Cancer: Global distribution pattern of histological subtypes of
epithelial ovarian cancer: A database analysis and systematic
review. Gynecol Oncol. 133:147–154. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang C, Guo Z, Wu C, Li Y and Kang S: A
polymorphism at the miR-502 binding site in the 3′ untranslated
region of the SET8 gene is associated with the risk of epithelial
ovarian cancer. Cancer Genet. 205:373–376. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Suh DH, Lee KH, Kim K, Kang S and Kim JW:
Major clinical research advances in gynecologic cancer in 2014.
Gynecol Oncol. 26:156–167. 2015. View Article : Google Scholar
|
|
6
|
Jayson GC, Kohn EC, Kitchener HC and
Ledermann JA: Ovarian cancer. Lancet. 384:1376–1388. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Munksgaard PS and Blaakaer J: The
association between endometriosis and gynecological cancers and
breast cancer: A review of epidemiological data. Gynecol Oncol.
123:157–163. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gram IT, Lukanova A and Brill I: Cigarette
smoking and risk of histological subtypes of epithelial ovarian
cancer in the EPIC cohort study. Int J Cancer. 130:2204e22102012.
View Article : Google Scholar
|
|
9
|
Chong GO, Jeon HS, Han HS, Son JW, Lee YH,
Hong DG, Lee YS and Cho YL: Differential MicroRNA Expression
Profiles in Primary and Recurrent Epithelial Ovarian Cancer.
Anticancer Res. 35:2611–2617. 2015.PubMed/NCBI
|
|
10
|
Eitan R, Kushnir M, Lithwick-Yanai G,
David MB, Hoshen M, Glezerman M, Hod M, Sabah G, Rosenwald S and
Levavi H: Tumor microRNA expression patterns associated with
resistance to platinum based chemotherapy and survival in ovarian
cancer patients. Gynecol Oncol. 114:253–259. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan Y, Fan J, Huang L, Ye M, Huang Z, Wang
Y, Li Q and Huang J: Increased expression of microRNA-196a predicts
poor prognosis in human ovarian carcinoma. Int J Clin Exp Pathol.
8:4132–4137. 2015.PubMed/NCBI
|
|
12
|
Yuan C, Liu X, Yan S, Wang C and Kong B:
Analyzing association of the XRCC3 gene polymorphism with ovarian
cancer risk. BioMed Res Int. 2014:6481372014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Diaz-Padilla I, Amir E, Marsh S, Liu G and
Mackay H: Genetic polymorphisms as predictive and prognostic
biomarkers in gynecological cancers: A systematic review. Gynecol
Oncol. 124:354–365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vella N, Aiello M, Russo AE, Scalisi A,
Spandidos DA, Toffoli G, Sorio R, Libra M and Stivala F: ‘Genetic
profiling’ and ovarian cancer therapy (Review). Mol Med Rep.
4:771–777. 2011.PubMed/NCBI
|
|
15
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wienholds E and Plasterk RH: MicroRNA
function in animal development. FEBS Lett. 579:5911–5922. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hatfield SD, Shcherbata HR, Fischer KA,
Nakahara K, Carthew RW and Ruohola-Baker H: Stem cell division is
regulated by the microRNA pathway. Nature. 435:974–978. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu Y, Yu CY, Wang JL, Guan J, Chen HY and
Fang JY: MicroRNA sequence polymorphisms and the risk of different
types of cancer. Sci Rep. 4:36482014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et
al: MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Christensen BC, Avissar-Whiting M, Ouellet
LG, Butler RA, Nelson HH, McClean MD, Marsit CJ and Kelsey KT:
Mature microRNA sequence polymorphism in MIR196A2 is associated
with risk and prognosis of head and neck cancer. Clin Cancer Res.
16:3713–3720. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee SJ, Seo JW, Chae YS, Kim JG, Kang BW,
Kim WW, Jung JH, Park HY, Jeong JY and Park JY: Genetic
polymorphism of miR-196a as a prognostic biomarker for early breast
cancer. Anticancer Res. 34:2943–2949. 2014.PubMed/NCBI
|
|
23
|
Hoffman AE, Zheng T, Yi C, Leaderer D,
Weidhaas J, Slack F, Zhang Y, Paranjape T and Zhu Y: microRNA
miR-196a-2 and breast cancer: A genetic and epigenetic association
study and functional analysis. Cancer Res. 69:5970–5977. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang N, Li Y, Zhu LJ, Zhou RM, Jin W, Guo
XQ, Wang CM, Chen ZF and Liu W: A functional polymorphism
rs11614913 in microRNA-196a2 is associated with an increased risk
of colorectal cancer although not with tumor stage and grade.
Biomed Rep. 1:737–742. 2013.PubMed/NCBI
|
|
25
|
Prat J: FIGO Committee on Gynecologic
Oncology: Staging classification for cancer of the ovary, fallopian
tube, and peritoneum. Int J Gynaecol Obstet. 124:1–5. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schroeder A, Mueller O, Stocker S,
Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M
and Ragg T: The RIN: an RNA integrity number for assigning
integrity values to RNA measurements. BMC Mol Biol. 7:32006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen PS, Su JL and Hung MC: Dysregulation
of microRNAs in cancer. J Biomed Sci. 19:902012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fabbri M, Calore F, Paone A, Galli R and
Calin GA: Epigenetic regulation of miRNAs in cancer. Adv Exp Med
Biol. 754:137–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Salzman DW and Weidhaas JB: SNPing cancer
in the bud: microRNA and microRNA-target site polymorphisms as
diagnostic and prognostic biomarkers in cancer. Pharmacol Ther.
137:55–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liang D, Meyer L, Chang DW, Lin J, Pu X,
Ye Y, Gu J, Wu X and Lu K: Genetic variants in MicroRNA
biosynthesis pathways and binding sites modify ovarian cancer risk,
survival, and treatment response. Cancer Res. 70:9765–9776. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu Q, Dong Q, He C, Liu W, Sun L, Liu J,
Xing C, Li X, Wang B and Yuan Y: A new polymorphism biomarker
rs629367 associated with increased risk and poor survival of
gastric cancer in Chinese by up-regulated miRNA-let-7a expression.
PLoS One. 9:e952492014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Slaby O, Bienertova-Vasku J, Svoboda M and
Vyzula R: Genetic polymorphisms and microRNAs: New direction in
molecular epidemiology of solid cancer. J Cell Mol Med. 16:8–21.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Srivastava K and Srivastava A:
Comprehensive review of genetic association studies and
meta-analyses on miRNA polymorphisms and cancer risk. PLoS One.
7:e509662012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nicoloso MS, Sun H, Spizzo R, Kim H,
Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L,
et al: Single-nucleotide polymorphisms inside microRNA target sites
influence tumor susceptibility. Cancer Res. 70:2789–2798. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shen J, Ambrosone CB, DiCioccio RA, Odunsi
K, Lele SB and Zhao H: A functional polymorphism in the miR-146a
gene and age of familial breast/ovarian cancer diagnosis.
Carcinogenesis. 29:1963–1966. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Peng S, Kuang Z, Sheng C, Zhang Y, Xu H
and Cheng Q: Association of microRNA-196a-2 gene polymorphism with
gastric cancer risk in a Chinese population. Dig Dis Sci.
55:2288–2293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L,
Zeng Y, Miao R, Jin G, Ma H, et al: Genetic variants of miRNA
sequences and non-small cell lung cancer survival. J Clin Invest.
118:2600–2608. 2008.PubMed/NCBI
|
|
39
|
Schimanski CC, Frerichs K, Rahman F,
Berger M, Lang H, Galle PR, Moehler M and Gockel I: High miR196a
levels promote the oncogenic phenotype of colorectal cancer cells.
World J Gastroenterol. 15:2089–2096. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhan JF, Chen LH, Chen ZX, Yuan YW, Xie
GZ, Sun AM and Liu Y: A functional variant in microRNA196a2 is
associated with susceptibility of colorectal cancer in a Chinese
population. Arch Med Res. 42:1441482011. View Article : Google Scholar
|
|
41
|
Chen H, Sun LY, Chen LL, Zheng HQ and
Zhang QF: A variant in microRNA196a2 is not associated with
susceptibility to and progression of colorectal cancer in Chinese.
Intern Med J. 42:e115–e119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pu JY, Dong W, Zhang L, Liang WB, Yang Y
and Lv ML: No association between single nucleotide polymorphisms
in pre-mirnas and the risk of gastric cancer in Chinese population.
Iran J Basic Med Sci. 17:128–133. 2014.PubMed/NCBI
|
|
43
|
Zhu R, Liu X, He Z and Li Q: miR-146a and
miR-196a2 polymorphisms in patients with ischemic stroke in the
northern Chinese Han population. Neurochem Res. 39:1709–1716. 2014.
View Article : Google Scholar : PubMed/NCBI
|
